A unique family of exchange traded funds (ETFs) are expected to launch Tuesday, January 23rd on the New York Stock Exchange. The HealthShares focus is to allow individuals and investors to narrowly choose where to put their money within the healthcare industry. Baskets of stocks range from companies who solely focus on either curing, diagnosing, or treating specific disease such as heart disease, cancer or diabetes.
Each fund is made up of a combination of small-,mid-,or large-cap companies focused on a therapeutic ‘Vertical’ or sub-segment of the complex healthcare, life-science and biotechnology industries. This methodology is a precise instrument that leverages the potential of healthcare investing while lowering the risk of single stock picking. Some of the Healthcare’s ETFs will include:
- HealthShares Cardio Devices
- HealthShares Emerging Cancer
- HealthShares Diagnostics
- HealthShares Enabling Technologies
- HealthShares Patient Care Services
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.